TW200740829A - Novel antibacterial compounds - Google Patents
Novel antibacterial compoundsInfo
- Publication number
- TW200740829A TW200740829A TW095128893A TW95128893A TW200740829A TW 200740829 A TW200740829 A TW 200740829A TW 095128893 A TW095128893 A TW 095128893A TW 95128893 A TW95128893 A TW 95128893A TW 200740829 A TW200740829 A TW 200740829A
- Authority
- TW
- Taiwan
- Prior art keywords
- antibacterial compounds
- novel antibacterial
- alkyl
- infections
- novel
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000006583 (C1-C3) haloalkyl group Chemical group 0.000 abstract 1
- DRLPWCAENQZXJT-UHFFFAOYSA-N 2-[(dimethylazaniumyl)amino]acetate Chemical compound CN(C)NCC(O)=O DRLPWCAENQZXJT-UHFFFAOYSA-N 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 229910004727 OSO3H Inorganic materials 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2005008573 | 2005-08-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200740829A true TW200740829A (en) | 2007-11-01 |
Family
ID=37620798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095128893A TW200740829A (en) | 2005-08-08 | 2006-08-07 | Novel antibacterial compounds |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20100222302A1 (zh) |
| EP (2) | EP1931684A2 (zh) |
| JP (1) | JP2009504631A (zh) |
| KR (1) | KR20080038397A (zh) |
| CN (1) | CN101238135B (zh) |
| AR (1) | AR054608A1 (zh) |
| AU (1) | AU2006277662A1 (zh) |
| BR (1) | BRPI0614730A2 (zh) |
| CA (1) | CA2616977A1 (zh) |
| IL (1) | IL189322A0 (zh) |
| MX (1) | MX2008001415A (zh) |
| NO (1) | NO20081180L (zh) |
| RU (1) | RU2008108477A (zh) |
| TW (1) | TW200740829A (zh) |
| WO (1) | WO2007017828A2 (zh) |
| ZA (1) | ZA200802194B (zh) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003031443A1 (en) | 2001-10-04 | 2003-04-17 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety |
| EP1620098B1 (en) | 2003-04-30 | 2008-06-11 | Morphochem Aktiengesellschaft Für Kombinatorische Chemie | Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
| DE10340485B4 (de) | 2003-09-03 | 2015-05-13 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden |
| US8158797B2 (en) | 2003-12-18 | 2012-04-17 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Oxazolidinone-quinolone hybrid antibiotics |
| PL1709044T5 (pl) | 2003-12-18 | 2014-03-31 | Morphochem Aktiengesellschaft Fuer Komb Chemie | Antybiotyki hybrydowe oksazolidynon-chinolon |
| US20080287396A1 (en) * | 2005-04-21 | 2008-11-20 | Targanta Therapeutica Inc. | Phosphonated Fluoroquinolones, Antibacterial Analogs Thereof, and Methods for the Prevention and Treatment of Bone and Joint Infections |
| US8124623B2 (en) | 2006-11-10 | 2012-02-28 | Actelion Pharmaceuticals Ltd. | 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials |
| CL2007003332A1 (es) | 2006-11-24 | 2008-06-20 | Actelion Pharmaceuticals Ltd | Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas. |
| CL2008001002A1 (es) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
| WO2011031744A1 (en) * | 2009-09-09 | 2011-03-17 | Achaogen, Inc. | Antibacterial fluoroquinolone analogs |
| AU2014273471B2 (en) | 2013-05-28 | 2019-10-03 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections |
| CA2912590C (en) | 2013-05-28 | 2022-11-29 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Oxazolidinone-quinolone hybrid antibacterials for the parenteral treatment or prophylaxis of bacterial diseases |
| US10087171B2 (en) | 2016-12-19 | 2018-10-02 | Actelion Pharmaceuticals Ltd | Crystalline forms of cadazolid |
| KR102476708B1 (ko) | 2017-11-01 | 2022-12-09 | 삼성전자주식회사 | 광학 필터, 및 이를 포함하는 카메라 모듈 및 전자 장치 |
| KR102673362B1 (ko) * | 2018-03-27 | 2024-06-05 | 삼성전자주식회사 | 근적외선 흡수 필름, 광학 필터 및 전자 장치 |
| CN115772176A (zh) * | 2022-12-02 | 2023-03-10 | 常州兰陵制药有限公司 | 左氧氟沙星关键药物中间体的合成方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL80114A0 (en) * | 1985-09-24 | 1986-12-31 | Hoffmann La Roche | Quinoline derivatives,their manufacture and pharmaceutical compositions containing them |
| DK164287A (da) | 1986-03-31 | 1987-10-01 | Sankyo Co | Quinolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling deraf og deres anvendelse |
| JPH04128288A (ja) * | 1990-09-18 | 1992-04-28 | Teikoku Chem Ind Corp Ltd | キノロンカルボン酸誘導体及びその製造方法 |
| JP2004518677A (ja) * | 2000-12-21 | 2004-06-24 | ファルマシア・アンド・アップジョン・カンパニー | 抗菌性キノロン誘導体および細菌感染を治療するためのその使用 |
| WO2003031443A1 (en) | 2001-10-04 | 2003-04-17 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety |
| BR0307151A (pt) | 2002-02-01 | 2004-12-07 | Astrazeneca Ab | Composto ou um sal do mesmo, processo para a preparação do mesmo, composição farmacêutica, uso do composto ou de um seu sal, método para produzir um efeito antiangiogênico e/ou redutor da permeabilidade vascular em um animal de sangue quente, como um ser humano, que necessita de um tratamento do tipo referido, e, processos para a preparação de 5-bromo-7- azaindol, e para a produção de 5-metóxi-7-azaindol |
| US6803469B2 (en) | 2002-08-05 | 2004-10-12 | The Procter & Gamble Company | Process for preparing quinolone antibiotic intermediates |
| EP1620098B1 (en) | 2003-04-30 | 2008-06-11 | Morphochem Aktiengesellschaft Für Kombinatorische Chemie | Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
| KR20060113625A (ko) * | 2003-07-02 | 2006-11-02 | 머크 앤드 캄파니 인코포레이티드 | 시클로프로필기 치환된 옥사졸리디논 항생제 및 그의유도체 |
| PL1709044T5 (pl) * | 2003-12-18 | 2014-03-31 | Morphochem Aktiengesellschaft Fuer Komb Chemie | Antybiotyki hybrydowe oksazolidynon-chinolon |
-
2006
- 2006-08-03 AR ARP060103389A patent/AR054608A1/es unknown
- 2006-08-07 JP JP2008525696A patent/JP2009504631A/ja active Pending
- 2006-08-07 TW TW095128893A patent/TW200740829A/zh unknown
- 2006-08-07 CN CN2006800290493A patent/CN101238135B/zh not_active Expired - Fee Related
- 2006-08-07 WO PCT/IB2006/052714 patent/WO2007017828A2/en active Application Filing
- 2006-08-07 CA CA002616977A patent/CA2616977A1/en not_active Abandoned
- 2006-08-07 US US12/063,305 patent/US20100222302A1/en not_active Abandoned
- 2006-08-07 RU RU2008108477/04A patent/RU2008108477A/ru not_active Application Discontinuation
- 2006-08-07 AU AU2006277662A patent/AU2006277662A1/en not_active Abandoned
- 2006-08-07 EP EP06795600A patent/EP1931684A2/en not_active Withdrawn
- 2006-08-07 MX MX2008001415A patent/MX2008001415A/es not_active Application Discontinuation
- 2006-08-07 KR KR1020087005799A patent/KR20080038397A/ko not_active Application Discontinuation
- 2006-08-07 EP EP10004213A patent/EP2256120A1/en not_active Withdrawn
- 2006-08-07 BR BRPI0614730A patent/BRPI0614730A2/pt not_active IP Right Cessation
-
2008
- 2008-02-06 IL IL189322A patent/IL189322A0/en unknown
- 2008-03-06 NO NO20081180A patent/NO20081180L/no not_active Application Discontinuation
- 2008-03-07 ZA ZA200802194A patent/ZA200802194B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0614730A2 (pt) | 2016-11-01 |
| EP1931684A2 (en) | 2008-06-18 |
| ZA200802194B (en) | 2009-03-25 |
| RU2008108477A (ru) | 2009-09-20 |
| AR054608A1 (es) | 2007-06-27 |
| US20100222302A1 (en) | 2010-09-02 |
| CA2616977A1 (en) | 2007-02-15 |
| KR20080038397A (ko) | 2008-05-06 |
| AU2006277662A1 (en) | 2007-02-15 |
| WO2007017828A2 (en) | 2007-02-15 |
| CN101238135B (zh) | 2011-05-11 |
| EP2256120A1 (en) | 2010-12-01 |
| CN101238135A (zh) | 2008-08-06 |
| MX2008001415A (es) | 2008-04-04 |
| JP2009504631A (ja) | 2009-02-05 |
| WO2007017828A3 (en) | 2007-07-19 |
| NO20081180L (no) | 2008-04-15 |
| IL189322A0 (en) | 2008-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200740829A (en) | Novel antibacterial compounds | |
| MX2009004764A (es) | Derivados de 5-hidroximetil-oxazolidin-2-ona. | |
| WO2008062379A3 (en) | 4- (2-oxo-oxazolidin-3yl)-phenoxymethyle derivativeas as antibacterials | |
| TW200833690A (en) | 3-H-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same | |
| MX351590B (es) | Antibioticos de oxazolidinona. | |
| MX2011011485A (es) | Sulfonamidas nematocidas. | |
| TW200800997A (en) | Chemical compounds | |
| NZ593111A (en) | Antibacterial compounds | |
| MX337516B (es) | Derivados de 1,2,4-tiazolidin-3-ona y uso en el tratamiento del cancer. | |
| MY142018A (en) | Thiophene derivatives as chk 1 inihibitors | |
| HK1113352A1 (en) | Chemical compounds | |
| HK1114375A1 (en) | Chemical compounds | |
| TW200740800A (en) | Oxazolidinone compounds, and compositions and methods related thereto | |
| IN2012DN00785A (zh) | ||
| AP2003002942A0 (en) | New derivatives of oxazolidinones as bacterial agents | |
| NZ545472A (en) | 7-(4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl)quinolonecarboxylic acid derivative | |
| TW200745106A (en) | Chemical compounds | |
| MX2008000079A (es) | Derivados de quinolina como agentes antibacterianos. | |
| MX2007001954A (es) | Heterociclicos fusionados seleccionados y sus usos. | |
| MXPA05009688A (es) | Derivados de naftiridina como agentes antibacterianos. | |
| WO2008035153A3 (en) | Process for the preparation of beta-lactam antibiotic | |
| UA97245C2 (en) | Aminoglycoside antibiotics | |
| MY146954A (en) | Macrolactone derivatives | |
| MX2009009074A (es) | Macrolidos basados en eritromicina. | |
| ATE490769T1 (de) | Neue antibiotika mit bis(1-aryl-5- tetrazolyl)methan-derivaten |